Entrar/Registro  
INICIO ENGLISH
 
Medicina Cutánea Ibero-Latino-Americana
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio


ENVÍO DE ARTÍCULOS






>Revistas >Medicina Cutánea Ibero-Latino-Americana >Año 2003, No. 3


Zanini M, Bertino D, Corrêa e Silva K, Camargo PLH, Landaman G, Freitas E
Eritroqueratodermia simétrica progressiva: relato de um caso esporádico e de surgimento tardio
Med Cutan Iber Lat Am 2003; 31 (3)

Idioma: Portugués
Referencias bibliográficas: 14
Paginas: 192-194
Archivo PDF: 162.73 Kb.


Texto completo




RESUMEN

Sin resumen.


Palabras clave: Sin palabras Clave


REFERENCIAS

  1. DiGiovanna JJ. Ichtyosiform dermatoses. In: Fitzpatrick TB, Freedberg IM, Eisen AZ et al. Dermatology in medicine general. New York: McGraw-Hill; 1999. 596-600.

  2. Griffiths WAD, Judge MR, Leigh IM. Disorders of keratinization. In: Rook A, Wilkinson DS, Ebling FJG. Textbook of dermatology. London: Blasckwell Science; 1998. 1533-36.

  3. Ruiz Maldonado R, Tamayo L, Del Castillo V, et al. Erythrokeratodermia progressive symmetrica. Dermatologica 1982; 164:133-41.

  4. Nir M, Tanzer F. Progressive symmetric erythrokeratodermia. Dermatologica 1978; 156:268-73.

  5. Nazarro V, Blanchet-Bardon C. Progressive symmetric erythrokeratodermia. Arch Dermatol 1986; 122:434-40.

  6. Macfarlane AE, Chapman SJ, Verbov JL. Is erythrokeratoderma one disorder? A clinical and ultrastructural study of two siblings. Br J Dermatol 1991; 124:487-91.

  7. Darier J. Erythrokératodermie verruqueuse en nappes, symétrique et progressive. Bull Soc Fr Dermatol Syphiligr 1911; 22:252-64.

  8. Gottfried I, Landau M, Glaser F, et al. A mutation in GJB3 is associated with recessive erythrokeratodermia variabilis (EKV) and leads to defective trafficking of the connexin 31 protein. Hum Mol Genet 2002; 11: 1311-16.

  9. Ishida-Yamamoto A, McGrath JA, Lam H, Iizuka H, Friedman RA, Christiano AM. The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet 1997; 61:581-9.

  10. Suga Y; Jarnik M; Attar PS et al. Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma. J Cell Biol 2000; 151:401-12.

  11. Ishida-Yamamoto A; Kato H; Kiyama H et al. Mutant loricrin is not crosslinked into the cornified cell envelope but is translocated into the nucleus in loricrin keratoderma. J Invest Dermatol 2000; 115:1088-94.

  12. Ishida-Yamamoto A; Tanaka H; Nakane H; Takahashi H; Hashimoto Y; Iizuka H. Programmed cell death in normal epidermis and loricrin keratoderma. Multiple functions of profilaggrin in keratinization. J Invest Dermatol Symp Proc 1999; 4:145-9.

  13. Cram DL. Erythrokeratoderma variabilis and variable circinate erythrokeratodermia. Arch Dermatol 1970; 101:68-73.

  14. Ruiz-Maldonado R, Tamayo L. Oral retinoid (Ro 10-9359) in children with lamellar ichthyosis, epidermolytic hyperkeratosis and symmetrical progressive erythrokeratoderma. Dermatologica 1980; 161:305-14.



>Revistas >Medicina Cutánea Ibero-Latino-Americana >Año2003, No. 3
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019